LFCR (Lifecore Biomedical) Cyclically Adjusted Book per Share: $6.48 (As of Mar. 2026)


LFCR Lifecore Biomedical Inc LFCR
55 GF Score
Price $4.97
GF Value $6.52
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Lifecore Biomedical Cyclically Adjusted Book per Share?

Lifecore Biomedical LFCR -3.78% 55 Cyclically Adjusted Book per Share is $6.48 as of Mar. 2026. GuruFocus rates LFCR with a GF Score™ of 55/100 and a GF Value™ of $6.52 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lifecore Biomedical's adjusted book value per share for the three months ended in Mar. 2026 was $-0.759. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.48 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Lifecore Biomedical's average Cyclically Adjusted Book Growth Rate was -12.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -2.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lifecore Biomedical was 9.80% per year. The lowest was -7.40% per year. And the median was 6.50% per year.

As of today (2026-06-30), Lifecore Biomedical's current stock price is $4.97. Lifecore Biomedical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $6.48. Lifecore Biomedical's Cyclically Adjusted PB Ratio of today is 0.77.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lifecore Biomedical was 2.37. The lowest was 0.19. And the median was 1.23.


Lifecore Biomedical  (NAS:LFCR) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lifecore Biomedical's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.97/6.48
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lifecore Biomedical was 2.37. The lowest was 0.19. And the median was 1.23.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lifecore Biomedical Cyclically Adjusted Book per Share Related Terms


Lifecore Biomedical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Lifecore Biomedical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Cyclically Adjusted Book per Share Chart

Lifecore Biomedical Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.49 9.02 8.70 8.03 7.16

Lifecore Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.38 7.16 6.95 6.64 6.48

LFCR vs ANIK, DERM, ASRT: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Cyclically Adjusted PB Ratio falls into.


LFCR
55GF Score
Lifecore Biomedical Inc LFCR
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifecore Biomedical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lifecore Biomedical's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.759/330.2130*330.2130
=-0.759

Current CPI (Mar. 2026) = 330.2130.

Lifecore Biomedical Quarterly Data

Book Value per Share CPI Adj_Book
201605 7.762 240.229 10.669
201608 7.903 240.849 10.835
201611 7.998 241.353 10.943
201702 8.153 243.603 11.052
201705 8.241 244.733 11.119
201708 8.346 245.519 11.225
201711 8.396 246.669 11.240
201802 9.023 248.991 11.966
201805 9.117 251.588 11.966
201808 9.131 252.146 11.958
201811 9.126 252.038 11.957
201902 9.311 252.776 12.163
201905 9.282 256.092 11.968
201908 9.090 256.558 11.700
201911 8.884 257.208 11.406
202002 8.487 258.678 10.834
202005 7.906 256.394 10.182
202008 7.563 259.918 9.608
202011 7.125 260.229 9.041
202102 6.978 263.014 8.761
202105 6.913 269.195 8.480
202108 6.580 273.567 7.942
202111 5.298 277.948 6.294
202202 4.887 283.716 5.688
202205 2.976 292.296 3.362
202208 3.274 296.171 3.650
202211 2.448 297.711 2.715
202302 1.128 300.840 1.238
202305 -0.143 304.127 -0.155
202308 -0.445 307.026 -0.479
202311 0.047 307.051 0.051
202402 0.579 310.326 0.616
202405 0.370 314.069 0.389
202408 -0.127 314.796 -0.133
202411 0.418 315.493 0.438
202502 0.060 319.082 0.062
202505 0.036 321.465 0.037
202509 -0.281 324.800 -0.286
202512 -0.379 324.054 -0.386
202603 -0.759 330.213 -0.759

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $6.48 mean?
Lifecore Biomedical (LFCR) has a Cyclically Adjusted Book per Share of $6.48 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lifecore Biomedical and its competitors.
Is Lifecore Biomedical's Cyclically Adjusted Book per Share too high?
Lifecore Biomedical's current Cyclically Adjusted Book per Share is $6.48. Overall, Lifecore Biomedical has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lifecore Biomedical's Cyclically Adjusted Book per Share compare to ANIK and DERM?
Lifecore Biomedical's Cyclically Adjusted Book per Share of $6.48 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lifecore Biomedical and its competitors. Lifecore Biomedical's current Cyclically Adjusted Book per Share is $6.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecore Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Lifecore Biomedical (LFCR) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.52, compared to a current price of $4.97 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is $6.48. Lifecore Biomedical's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Lifecore Biomedical (LFCR), the current Cyclically Adjusted Book per Share is $6.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecore Biomedical (LFCR) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued. The current stock price of $4.97 is trading 23.8% below its estimated GF Value™ of $6.52. GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.

Key valuation signals for LFCR:

  • Cyclically Adjusted Book per Share: $6.48
  • GF Value™: $6.52 vs. price of $4.97 (23.8% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the LFCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lifecore Biomedical Business Description

Other Exchanges LDE:Germany
Address 3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
55GF Score

Get the complete analysis for LFCR

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.97
Price
$6.52
GF Value